Our data open a new window for a discussion for IGF-I as a pharmacological agent in prevention and treatment in patients with sarcopenia, as it might be the vital hormone for establishing a sufficient environment for muscle regeneration in age by supporting neuronal reinnervation of denervated muscle fibers. Here, IGF1 is linked to sarcopenia.